Charles Schwab Investment Management Inc Dice Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$25.86 - $46.71 $264,056 - $476,955	10,211 Added 4.0%	265,763 $12.3 Million
Q1 2023 May 11, 2023	BUY	$26.05 - $32.31 $59,263 - $73,505	2,275 Added 0.9%	255,552 $7.32 Million
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $1.28 Million - $2.73 Million	64,601 Added 34.24%	253,277 $7.9 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $971,118 - $1.47 Million	64,871 Added 52.4%	188,676 $3.83 Million
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $378,869 - $634,800	28,724 Added 30.21%	123,805 $1.92 Million
Q1 2022 May 13, 2022	BUY	$14.54 - $25.02 $42,703 - $73,483	2,937 Added 3.19%	95,081 $1.82 Million
Q4 2021 Feb 11, 2022	BUY	$22.41 - $37.54 $2.06 Million - $3.46 Million	92,144 New	92,144 $2.33 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.